|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.58 USD | +2.13% |
|
+5.05% | -23.15% |
| 07-13 | Amphastar Pharmaceuticals, Inc. Announces Board Changes, Effective July 9, 2026 | CI |
| 07-08 | Amphastar Unit Receives US FDA Warning Letter on Violations at California Facility | MT |
Company Valuation: Amphastar Pharmaceuticals, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,114 | 1,354 | 2,963 | 1,785 | 1,231 | 907.4 | - | - |
| Change | - | 21.52% | 118.8% | -39.75% | -31.07% | -26.26% | - | - |
| Enterprise Value (EV) 1 | 1,114 | 1,354 | 2,963 | 2,235 | 1,231 | 1,233 | 1,108 | 987.8 |
| Change | - | 21.52% | 118.8% | -24.56% | -44.95% | 0.17% | -10.15% | -10.82% |
| P/E | 18.6x | 16.1x | 23.8x | 12.1x | 13.2x | 15.4x | 11.7x | 12.8x |
| PBR | - | - | - | 2.41x | 1.55x | 1.04x | - | - |
| PEG | - | 0.4x | 0.5x | 0.7x | -0.4x | -0.5x | 0.4x | -1.5x |
| Capitalization / Revenue | 2.55x | 2.71x | 4.6x | 2.44x | 1.71x | 1.22x | 1.17x | 1.13x |
| EV / Revenue | 2.55x | 2.71x | 4.6x | 3.05x | 1.71x | 1.65x | 1.42x | 1.22x |
| EV / EBITDA | 11.2x | 9.21x | 10.4x | 7.18x | 4.97x | 6.12x | 5.11x | 4.51x |
| EV / EBIT | 14.5x | 11.1x | 12.1x | 8.66x | 5.7x | 7.26x | 5.86x | 4.94x |
| EV / FCF | - | 20.8x | - | 13x | 10.2x | 10.8x | 8.86x | 8.23x |
| FCF Yield | - | 4.81% | - | 7.71% | 9.85% | 9.25% | 11.3% | 12.1% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.25 | 1.74 | 2.6 | 3.06 | 2.03 | 1.34 | 1.76 | 1.61 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 437.8 | 499 | 644.4 | 732 | 719.9 | 745.2 | 778.7 | 806.4 |
| EBITDA 1 | 99.1 | 147.1 | 283.9 | 311.1 | 247.5 | 201.5 | 216.8 | 219.1 |
| EBIT 1 | 76.9 | 121.8 | 245.8 | 258.2 | 215.9 | 169.7 | 189 | 200.1 |
| Net income 1 | 62.12 | 91.39 | 137.5 | 159.5 | 98.09 | 64 | 84 | 79 |
| Net Debt 1 | - | - | - | 450 | - | 325.3 | 200.2 | 80.32 |
| Reference price 2 | 23.29 | 28.02 | 61.85 | 37.13 | 26.78 | 20.58 | 20.58 | 20.58 |
| Nbr of stocks (in thousands) | 47,849 | 48,331 | 47,907 | 48,081 | 45,952 | 44,093 | - | - |
| Announcement Date | 3/10/22 | 2/28/23 | 2/28/24 | 2/27/25 | 2/26/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 15.04x | 1.63x | 6.02x | -.--% | 888M | |
| 36.25x | 12.94x | 27.18x | 0.55% | 1,089B | |
| 28.59x | 6.53x | 18.09x | 2.01% | 643B | |
| 33.13x | 7.75x | 15.94x | 2.61% | 465B | |
| 20.2x | 4.86x | 12.04x | 2.72% | 359B | |
| 22.65x | 5.84x | 14.57x | 2.74% | 303B | |
| 22.03x | 4.53x | 12.8x | 1.93% | 267B | |
| 14.79x | 5.48x | 11.3x | 3.38% | 226B | |
| 25.81x | 6.73x | 11.86x | 2.57% | 212B | |
| -48.4x | 5.8x | 32.01x | 2.45% | 167B | |
| Average | 17.01x | 6.21x | 16.18x | 2.1% | 373.2B | |
| Weighted average by Cap. | 25.19x | 8.11x | 19.08x | 1.92% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- AMPH Stock
- Valuation Amphastar Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
